CN103690884A - Anti-tumor Chinese medicinal composition - Google Patents
Anti-tumor Chinese medicinal composition Download PDFInfo
- Publication number
- CN103690884A CN103690884A CN201310691274.5A CN201310691274A CN103690884A CN 103690884 A CN103690884 A CN 103690884A CN 201310691274 A CN201310691274 A CN 201310691274A CN 103690884 A CN103690884 A CN 103690884A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- root
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an anti-tumor Chinese medicinal composition, which is prepared from the following raw materials in parts by weight: 15-20 parts of astragalus, 10-15 parts of curcuma zedoary, 5-10 parts of glaucescent fissistigma root, 9-16 parts of spreading hedyotis herb, 7-13 parts of American ginseng, 10-15 parts of barbed skullcap herb, 5-10 parts of Chinese angelica, 10-15 parts of Chinese actinidia root, 5-10 parts of cochinchnese asparagus root, 10-15 parts of walnut kernel, 15-20 parts of coix seed, 8-14 parts of rabdosia rubescens, 10-15 parts of poria cocos, 5-10 parts of levant cotton root, 12-18 parts of lucid ganoderma, 15-20 parts of common andrographis herb, 16-22 parts of sunflower stem pith, 10-15 parts of solanum lyratum thunb, 5-10 parts of ginseng flower, 10-15 parts of salvia prionitis, 5-10 parts of common selfheal fruit-spike, 5-10 parts of fiveleaf gynostemma herb, 10-15 parts of cordyceps sobolifera, 5-10 parts of kudzuvine root and 10-15 parts of turmeric. The Chinese medicinal composition has a remarkable antitumor effect, can control the growth of tumors and eliminate tumor in a short period of time, can remarkably improve the physique of a human body, enhance the disease-resistant recovery capacity and prolong the life of a tumor patient, has good treatment effects on tumors of every stage, has the advantages of stable pharmaceutical effect, quick absorption, quick response, reliable curative effect, short treatment period, no remarkable toxic or side effect, is worthy of large-scale industrial production, and is easier to popularize.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, be specifically related to a kind of antitumor Chinese.
Background technology
Tumor be body under various carcinogenic factor effects, some cells of local organization lose the normal regulation to its growth on gene level, cause its clonal abnormality hypertrophy and the abnormality that forms.Tumor is one of major disease of current serious threat people life security, no matter both at home and abroad, has a large amount of patients dead because suffering from tumor every year.At the sickness rate when pre-neoplastic, constantly rising, is frequently-occurring disease, commonly encountered diseases from rare sick development, becomes healthy primary killer.Chinese traditional treatment tumor is the characteristic of China, the advantage of Ye Shi China.For a long time, though TCM on Tumor has been obtained certain methods and experience, also exist at present the course for the treatment of not good, treatment cycle is long, and fundamentally tumor, therefore cannot be worth generally pushing away completely.
Summary of the invention
The object of the invention is to for the deficiencies in the prior art, the antitumor Chinese that a kind of therapeutic effect is good, treatment cycle is short, toxic and side effects is little is provided.
For achieving the above object, the present invention adopts following technical scheme:
A kind of antitumor Chinese, raw material by following weight portion is made: Radix Astragali 15-20, Rhizoma Curcumae 10-15, Radix Fissistigmatis Glaucescentis 5-10, Herba Hedyotidis Diffusae 9-16, Radix Panacis Quinquefolii 7-13, Herba Scutellariae Barbatae 10-15, Radix Angelicae Sinensis 5-10, Radix Actinidiae Chinensis 10-15, Radix Asparagi 5-10, Semen Juglandis 10-15, Semen Coicis 15-20, Rabdosia rubescens 8-14, Poria 10-15, Radix Gossypii 5-10, Ganoderma 12-18, Herba Andrographis 15-20, Medulla Helianthi 16-22, Herba Solani Lyrati 10-15, Flos Ginseng 5-10, Arisaema balansae Engl. grass 10-15, Spica Prunellae 5-10, Herb Gynostemmae Pentaphylli 5-10, Periostracum cicadae 10-15, Radix Puerariae 5-10, Rhizoma Curcumae Longae 10-15.
Preferably, an antitumor Chinese, is made by the raw material of following weight portion: the Radix Astragali 20, Rhizoma Curcumae 15, Radix Fissistigmatis Glaucescentis 6, Herba Hedyotidis Diffusae 13, Radix Panacis Quinquefolii 11, Herba Scutellariae Barbatae 12, Radix Angelicae Sinensis 8, Radix Actinidiae Chinensis 12, Radix Asparagi 8, Semen Juglandis 12, Semen Coicis 18, Rabdosia rubescens 12, Poria 15, Radix Gossypii 8, Ganoderma 16, Herba Andrographis 18, Medulla Helianthi 20, Herba Solani Lyrati 15, Flos Ginseng 8, Arisaema balansae Engl. grass 15, Spica Prunellae 8, Herb Gynostemmae Pentaphylli 7, Periostracum cicadae 15, Radix Puerariae 8, Rhizoma Curcumae Longae 12.
Usage and consumption: be decocted in water for oral dose, 1 dose of every day, day takes 2-3 time.
Beneficial effect of the present invention:
Chinese medicine composition antitumous effect of the present invention is remarkable, both can control in a short time the growth of tumor, eliminates tumor, can also significantly strengthen human body constitution simultaneously, improves himself disease-resistant repair ability, to extend tumor
Patient's life, has good therapeutic effect to the tumor in each period, and efficacy stability absorbs rapidly, instant effect, and curative effect is reliable, and treatment cycle is short, there is no obvious toxic and side effects, is worth large-scale industrial production, easier penetration and promotion.
The specific embodiment
An antitumor Chinese, is made by the raw material of following weight (g): the Radix Astragali 20, Rhizoma Curcumae 15, Radix Fissistigmatis Glaucescentis 6, Herba Hedyotidis Diffusae 13, Radix Panacis Quinquefolii 11, Herba Scutellariae Barbatae 12, Radix Angelicae Sinensis 8, Radix Actinidiae Chinensis 12, Radix Asparagi 8, Semen Juglandis 12, Semen Coicis 18, Rabdosia rubescens 12, Poria 15, Radix Gossypii 8, Ganoderma 16, Herba Andrographis 18, Medulla Helianthi 20, Herba Solani Lyrati 15, Flos Ginseng 8, Arisaema balansae Engl. grass 15, Spica Prunellae 8, Herb Gynostemmae Pentaphylli 7, Periostracum cicadae 15, Radix Puerariae 8, Rhizoma Curcumae Longae 12.
Usage and consumption: be decocted in water for oral dose, 1 dose of every day, day takes 2-3 time.
Model case:
Case 1: poplar, man, 44 years old.Element body is healthy, sleep food all can, before 3 years, found that there is one 2 * 3 * 1.5cm at left shoulder back
3the lump of size, the soft smooth of pressing, painless being subject to, the colour of skin is normal, therefore do not take notice of.Accidentally once, because of abdominal distention, diarrhoea, certainly take Ginseng Bolus for tonifying spleen's one box, aftersensation lump disappears more than half.In June, 2010, lump increased to 5 * 4 * 3cm again because of tired and negative stimulation
3size, the soft hypodynia of pressing, surface color is slightly purple dark, and doctor trained in Western medicine is examined as " sebaceous cyst concurrent infection ".After recollect and took above-mentioned prescription last time it is dwindled, again from taking 15 doses, lump is eliminated again more than half really, does not ache.Take 20 doses, lump disappears again, and only local color is slightly dark, the recurrence of following up a case by regular visits to that so far there are no.
Case 2: Zhu, female, 45 years old.Before half a year, there is vagina irregularly hemorrhage, think that climacteric do not give diagnosis and treatment, hemorrhage gradually many afterwards, leukorrhagia, lumbago, pin down leg pain, through certain hospital diagnosis, be uterus carcinoma late period, patient face, as in the shade TofieldiadivergensBur.etFra-nch., is bent over, is walked with difficulty, and oneself premonition is checkmated.Give the treatment of above-mentioned prescription, take after 20 days, lumbago, hemorrhagely all stops, and appetite is promoted.Following the service 1 month, spirit is completely healthy, and all disease knowing are removed, recovery from illness.The recurrence of following up a case by regular visits to that so far there are no.
Case 3: Fang, female, 56 years old.Patient element body is strong, amenorrhea in 48 years old, and medical former Tiantus are felt lumbagos, stomachache, lack of appetite, day by day becomes thin, and then occurs lower abdomen twinge, colporrhagia sexual secretion, color is black dull rotten odor.Through gynecologial examination, examine as the cervical cancer III phase, lost surgical engine meeting.I refuse chemotherapy, through a course for the treatment of of radiotherapy less than, because not tolerating, interrupt, and turn here diagnosis and treatment.Disease is seen: shallow complexion, and the thin skin of shape is withered, and lip is light red, lower abdomen tenderness, red tongue has ecchymosis, yellow and greasy fur, deep-thready pulse, examines as blood stasis disease, is taken more than the above-mentioned prescription moon, and lumbago slightly subtracts, remaining disease does not eliminate, and rear following the service is after 2 months, and vagina depletion of blood sexual secretion is discharged, and all cards are known flat altogether.Follow up a case by regular visits to so far without recurrence, the work of having gone to work.
Claims (2)
1. an antitumor Chinese, it is characterized in that, raw material by following weight portion is made: Radix Astragali 15-20, Rhizoma Curcumae 10-15, Radix Fissistigmatis Glaucescentis 5-10, Herba Hedyotidis Diffusae 9-16, Radix Panacis Quinquefolii 7-13, Herba Scutellariae Barbatae 10-15, Radix Angelicae Sinensis 5-10, Radix Actinidiae Chinensis 10-15, Radix Asparagi 5-10, Semen Juglandis 10-15, Semen Coicis 15-20, Rabdosia rubescens 8-14, Poria 10-15, Radix Gossypii 5-10, Ganoderma 12-18, Herba Andrographis 15-20, Medulla Helianthi 16-22, Herba Solani Lyrati 10-15, Flos Ginseng 5-10, Arisaema balansae Engl. grass 10-15, Spica Prunellae 5-10, Herb Gynostemmae Pentaphylli 5-10, Periostracum cicadae 10-15, Radix Puerariae 5-10, Rhizoma Curcumae Longae 10-15.
2. antitumor Chinese according to claim 1, it is characterized in that, by the raw material of following weight portion, made: the Radix Astragali 20, Rhizoma Curcumae 15, Radix Fissistigmatis Glaucescentis 6, Herba Hedyotidis Diffusae 13, Radix Panacis Quinquefolii 11, Herba Scutellariae Barbatae 12, Radix Angelicae Sinensis 8, Radix Actinidiae Chinensis 12, Radix Asparagi 8, Semen Juglandis 12, Semen Coicis 18, Rabdosia rubescens 12, Poria 15, Radix Gossypii 8, Ganoderma 16, Herba Andrographis 18, Medulla Helianthi 20, Herba Solani Lyrati 15, Flos Ginseng 8, Arisaema balansae Engl. grass 15, Spica Prunellae 8, Herb Gynostemmae Pentaphylli 7, Periostracum cicadae 15, Radix Puerariae 8, Rhizoma Curcumae Longae 12.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310691274.5A CN103690884A (en) | 2013-12-17 | 2013-12-17 | Anti-tumor Chinese medicinal composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310691274.5A CN103690884A (en) | 2013-12-17 | 2013-12-17 | Anti-tumor Chinese medicinal composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103690884A true CN103690884A (en) | 2014-04-02 |
Family
ID=50352654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310691274.5A Pending CN103690884A (en) | 2013-12-17 | 2013-12-17 | Anti-tumor Chinese medicinal composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103690884A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105796733A (en) * | 2016-04-18 | 2016-07-27 | 张瑞武 | Traditional Chinese medicine composition for preventing cancers and preparation method thereof |
CN105999123A (en) * | 2016-07-29 | 2016-10-12 | 王锦生 | Pure traditional Chinese medicine prescription for treating breast cancer and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101485830A (en) * | 2009-02-19 | 2009-07-22 | 宋小冰 | Pure Chinese medicine anti-aging health-care capsule |
CN103041312A (en) * | 2013-01-10 | 2013-04-17 | 南京海昌中药集团有限公司 | Traditional Chinese medicine composition with antineoplastic effect and preparation method and application thereof |
-
2013
- 2013-12-17 CN CN201310691274.5A patent/CN103690884A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101485830A (en) * | 2009-02-19 | 2009-07-22 | 宋小冰 | Pure Chinese medicine anti-aging health-care capsule |
CN103041312A (en) * | 2013-01-10 | 2013-04-17 | 南京海昌中药集团有限公司 | Traditional Chinese medicine composition with antineoplastic effect and preparation method and application thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105796733A (en) * | 2016-04-18 | 2016-07-27 | 张瑞武 | Traditional Chinese medicine composition for preventing cancers and preparation method thereof |
CN105999123A (en) * | 2016-07-29 | 2016-10-12 | 王锦生 | Pure traditional Chinese medicine prescription for treating breast cancer and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103041317B (en) | A kind of Chinese medicine composition for the treatment of tumor and preparation method thereof | |
CN102423408A (en) | Traditional Chinese medicine wine with functions of kidney reinforcing and yang strengthening | |
CN103463500B (en) | Medicament for treating cerebral hemorrhage | |
CN103285206B (en) | Traditional Chinese medicinal liquor for treating rheumatic arthritis | |
CN103142750A (en) | Rhubarb and eupolnhagea oral liquid and preparation method thereof | |
CN103690884A (en) | Anti-tumor Chinese medicinal composition | |
CN103301438A (en) | Traditional Chinese medicine composition for treating gastroptosis and preparation method thereof | |
CN102988887A (en) | Chinese medicament for treating ovarian cyst | |
CN103705846B (en) | The Chinese medicine preparation for the treatment of ovarian cyst | |
CN100404061C (en) | Chinese medicinal composition for treating chronic pharygitis | |
CN103272159A (en) | Chinese herbal preparation used for treating consumptive disease and preparation method thereof | |
CN106309749A (en) | Traditional Chinese medicine for treating cervical cancer | |
CN104623605A (en) | Traditional Chinese medicine capable of treating breast cancer | |
CN102205067B (en) | Traditional Chinese medicine composition for treating chronic urticaria | |
CN105147791A (en) | Quick-acting traditional Chinese medicine composition for treating skin diseases of acnes and chloasma | |
CN104083580A (en) | Traditional Chinese medicine for treating senile dementia | |
CN104740075A (en) | Traditional Chinese medicine for treating periomethritis | |
CN101130034A (en) | Traditional Chinese medicine composition for treating gland hyperplasia | |
CN103800664A (en) | Traditional Chinese medicine composition for treating menopausal syndrome | |
CN102886017A (en) | Traditional Chinese medicine for treating ovarian cyst | |
CN103479960A (en) | Chronic Hepatitis B disease treatment Chinese herbal | |
CN102552541B (en) | Medicinal composition for preventing or treating breast cancer | |
CN106389598A (en) | Traditional Chinese medicine composition for curing purpura | |
CN102166340B (en) | Chinese medicine composition for treating sthenia heat edema | |
CN101850101A (en) | Chinese medicinal composition for treating metrostaxis and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140402 |